SlideShare a Scribd company logo
1 of 20
Characterization of Long-Lived Cyclotron Produced
Activation Metal Impurities Retained in FASTlab FDG
Cassettes during Synthesis of Radiolabeled 2-[18F] fluoro-2-
deoxy-D-glucose (FDG)
Presented at the 60th Annual Health Physics Society Meeting
Paul Swearingen, MHP
MOLECULAR IMAGING PROGRAM AT STANFORD
STANFORD HEALTH PHYSICS
Introduction
 PET radiopharmaceutical production on the rise
› Proportional increase in PET production sites worldwide
› Produced via Cyclotron
 Stanford Cyclotron and Radiochemistry Facility (CRF)
› F18 radiolabeled FDG production
› Supports clinical and research use
› Daily production
 Health Physics Functions
› Radioactive materials license
› Personnel monitoring
› ALARA
› Radioactive waste
Paul Swearingen, MHP
3
Cyclotron and Radiochemistry Facility (CRF)
 16.5 MeV General Electric PETtrace
Cyclotron accelerator
› Protons/deuterons fired onto target
› Up to 6 targets
› Designed to produce common PET
radioisotopes
 Radiochemistry Systems
› Automated/Isolated
› Stand-alone process units for
specific radioisotopes
› Housed in lead shielded process
cabinet
Paul Swearingen, MHP
4
FASTlab Synthesizer
 Automated radiochemistry system
› GE Heath Care Design
› converts externally produced
18F-fluoride/into [18F]-Tracer
 FDG production via individual
tracer cassettes
 Stanford uses FDG citrate
cassettes
Paul Swearingen, MHP
FDG Citrate Cassette
End Tubing
Eluent Vial
Alumina
Cartridge
Purification
Cartridge
Right Hand
6 ml Syringe
Trapping
Cartridge Reaction Vessel
Reagent Vials
Hydrolysis
Cartridge
Transfer Tubing
Left Hand 6 ml
Syringe
Paul Swearingen, MHP
Target Irradiation
 Charged particles accelerated and deflected onto target
› Enriched O-18 water target
› Secondary reactions in surrounding materials
› Proton/neutron activation in target and housing/shielding
 Activation metals leach into target water from surrounding materials
› Mainly from Havar Foils
• Co, Cr, Fe, Ni, Mn, W, Mo metals
› Cassettes retain activation metals
• Activity not uniformly distributed among components
Paul Swearingen, MHP
7
Radioactive Waste
 Short-lived wastes
› F18 and other PET isotopes
› Decay-in-storage method (DIS)
 Long-lived wastes
› Target components
› FDG Cassettes
› Accumulation of waste
› Current disposal method vs.
DIS method
› Need to characterize
• Isotopes, activities, cassette
components
Paul Swearingen, MHP
Waste Characterization
 Unknown isotopes and activity amounts
› Gamma spectroscopy using HPGe
 Characterize isotopes in cassettes
› Determine half-lives and activities
› Determine required DIS time
 Determine radioactive components
› Distribution of isotope activities
› Reduce overall volume of waste
Paul Swearingen, MHP
Experiment Steps
 Collect cassettes from Cyclotron
› Coordinate with radiochemistry staff
› Separate components into 11 countable samples
› Collected total of 5 cassettes over 5 month period
› Random selection of cassettes
 Count samples using HPGe
› 12 hour counting time
› Repeatable geometry
› Background counts
› Acquire gamma ray spectra of each sample
› Collect activity and isotope data
 Data Analysis
› Determine distribution of isotopes/activities in each sample
› Determine required DIS times
Paul Swearingen, MHP
Paul Swearingen, MHP
Stanford HPGe Lab
 Ortec GMX Series Coaxial Detector System
› Model GMX20-70-CW
› N-Type Crystal
› Bias Voltage at 4000V
› DSPEC-jr. 2.0 MCA
› GammaVision v7.02 Software
 Energy and Efficiency Calibration
› Eckert & Ziegler Multi-gamma check source (AD-7066)
› 60 – 1836 KeV
 Lead shielded enclosure
› Low sample counts
› Important to minimize background
› 12 hr background spectrum before every run
Paul Swearingen, MHP
Isotope Composition at Irradiation
Co-56, 33.4%
Co-57, 0.9%
Co-58, 9.4%
Cr-51, 22.3%
Mn-52, 7.7%
Mn-54, 0.5%
Ni-57, 5.3%
Re-181, 1.7%
Re-182, 0.4%
Re-184, 0.4%
Tc-95, 5.7%
Tc-95m, 1.8%
Tc-96, 9.0%
V-48, 0.1%
Y-88, 1.2%
Zn-65, 0.3%
Zr-89, 0.1%
Paul Swearingen, MHP
Activity by Counting Sample
Right Hand 6 ml Syringe,
0.5%
Purification Cartridge,
0.9%
Alumina Cartridge, 6.7%
Transfer Tubing, 1.6%
Hydrolysis Cartridge,
5.0%
Reagent Vials Unit, 0.1%
Reaction Vessle, 8.9%
Left Hand 6 ml
Syringe, 13.0%
Trapping
Cartridge,
47.6%
Eluent Vial + 1 ml
Syringe, 11.9%
End Tubing, 3.6%
Paul Swearingen, MHP
14 10 CFR PART 30 —RULES OF GENERAL
APPLICABILITY TO DOMESTIC
LICENSING OF BYPRODUCT MATERIAL
Exemption Limits
 § 30.70 Schedule A--Exempt
concentrations
› Specific activity limits for
various isotopes
› For multiple isotopes,
combined ratio must not
exceed unity
Isotope Concentration [μCi/mg]
Cd-109 2.00E-03
Co-56 1.00E-06
Co-57 5.00E-03
Co-58 1.00E-03
Cr-51 2.00E-02
Mn-52 3.00E-04
Mn-54 1.00E+00
Ni-57 1.00E-03
Re-182 1.00E-06
Re-183 6.00E-03
Re-184 1.00E-06
Re-186 9.00E-04
Tc-95m 1.00E-06
Tc-96 1.00E-03
V-48 3.00E-04
W-181 1.00E-06
Y-88 1.00E-06
Zn-65 1.00E-03
Paul Swearingen, MHP
Summary of Results
 16 isotopes in 5 cassettes
› 0.8 – 312 day half-lives
› 122 – 1434 KeV gammas
› 0.01 – 1.2 uCi activities
 Stanford “Decay-in-Storage” (DIS) policy
› Per our license with State of California
› DIS for 7 half-lives, if half-life less than 120 d
 All but 2 components are non-exempt
› Co-56/Tc-95m
› 77.2 and 62 day half-lives
Paul Swearingen, MHP
Conclusions
 Co-56 is the longest lived, non-exempt isotope
› 77.2 day half life
› 540 day DIS time per cassette
› After DIS  dispose as non-radioactive waste
 DIS of entire cassette better option
 All but 2 components considered non-radioactive
› ≈22% volume reduction
 Insufficient statistics to verify radioactive vs. non-radioactive components
› Small sample size (n = 5)
 Time, Distance, Shielding
› Dose considerations working directly with cassettes
Paul Swearingen, MHP
Future Considerations
 Develop Standard Operating Procedure for DIS and handling of Cassettes
 Institute routine waste pick-up policy for wastes containing activated
metals
› Daily throughput  estimate of 30 cassettes/month
 Further analysis
› More Cassettes, better statistics  determine radioactive vs. non-
radioactive components with greater degree of certainty
› Relationship between cyclotron irradiation conditions and isotope
composition
› Cost-benefit analysis
 ALARA considerations
› Dose to worker estimates
› Shielding
Paul Swearingen, MHP
Acknowledgements
Dawn Banghart, CHP Stanford Health Physics
Lance Phillips, CHP Stanford Health Physics
Don Samaan, NRRPT Stanford Health Physics
Marshall Wen Stanford Health Physics
Fred T. Chin, PhD Assistant Professor (Research), Assistant Professor
(Research), Radiology- Molecular Imaging Program at
Stanford
Bin Shen, PhD Radiochemistry Senior Research
Associate
George Montoya Cyclotron Production Technician
Paul Swearingen, MHP
Questions?
Paul Swearingen, MHP
References
Ferguson, D. et al., “Measurement of long lived radioactive impurities retained in the
disposable cassettes on the Tracerlab MX system during the production of
F18[FDG]”, Appl. Radiat. Isotopes (2011)
O’Donnell, R.G., “Measurement of the residual radioactivity induced in the front foil
of a target assembly in a modern medical cyclotron”, Appl. Radiat. Isotopes (2003)
LNHB Recommended Data. LNHB, 21 May 2015. Web. 15 June 2015.
<http://www.nucleide.org/DDEP_WG/DDEPdata.htm>.
Radionuclide Transofrmations: Energy and Intensity of Emissions. ICRP Publication
38 ed. Vol. 11-13. Oxford: Pergamon, 1983. Print.
PETtrace Reference Manual. Milwuakee: GE Medical Systems, 1998. Print.
FASTlab FDG Citrate Application Manual. Waukesha: GE Healthcare. Print.
Paul Swearingen, MHP

More Related Content

Similar to TAM-D.5

Automate Express to Streamline Differential Extraction process
Automate Express to Streamline Differential Extraction processAutomate Express to Streamline Differential Extraction process
Automate Express to Streamline Differential Extraction processThermo Fisher Scientific
 
Total Legal: A “Joint” Journey into the Chemistry of Cannabinoids
Total Legal: A “Joint” Journey into the Chemistry of CannabinoidsTotal Legal: A “Joint” Journey into the Chemistry of Cannabinoids
Total Legal: A “Joint” Journey into the Chemistry of CannabinoidsMarkus Roggen
 
Getting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in RadiopharmaceuticalsGetting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in RadiopharmaceuticalsMedpace
 
Trial examining the impact of various biological organic and fertiliser treat...
Trial examining the impact of various biological organic and fertiliser treat...Trial examining the impact of various biological organic and fertiliser treat...
Trial examining the impact of various biological organic and fertiliser treat...Gilba Solutions Pty Ltd
 
Lignocellulose Biomass- Hydrolysis & Fermentation Lab Protocols
Lignocellulose Biomass- Hydrolysis & Fermentation Lab ProtocolsLignocellulose Biomass- Hydrolysis & Fermentation Lab Protocols
Lignocellulose Biomass- Hydrolysis & Fermentation Lab ProtocolsBiorefineryEPC™
 
4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...dominev
 
Research on Safety of Electronic Cigarettes - Dr. Konstantinos Farsalinos
Research on Safety of Electronic Cigarettes - Dr. Konstantinos FarsalinosResearch on Safety of Electronic Cigarettes - Dr. Konstantinos Farsalinos
Research on Safety of Electronic Cigarettes - Dr. Konstantinos FarsalinosLindsay Fox
 
Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...
Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...
Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...OSU_Superfund
 
Chemical Analysis Facility
Chemical Analysis FacilityChemical Analysis Facility
Chemical Analysis Facilitychristinejcardin
 
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...Tomsk Polytechnic University
 
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC METHOD FOR D...
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC  METHOD FOR D...DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC  METHOD FOR D...
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC METHOD FOR D...Dipak Reddy
 
Are You Ready for Harmful Algal Bloom Season? | Preparing for HAB Monitoring
Are You Ready for Harmful Algal Bloom Season? | Preparing for HAB MonitoringAre You Ready for Harmful Algal Bloom Season? | Preparing for HAB Monitoring
Are You Ready for Harmful Algal Bloom Season? | Preparing for HAB MonitoringXylem Inc.
 
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...Greenlight Guru
 
academic / small company collaborations for rare and neglected diseasesv2
 academic / small company collaborations for rare and neglected diseasesv2 academic / small company collaborations for rare and neglected diseasesv2
academic / small company collaborations for rare and neglected diseasesv2Sean Ekins
 

Similar to TAM-D.5 (20)

Automate Express to Streamline Differential Extraction process
Automate Express to Streamline Differential Extraction processAutomate Express to Streamline Differential Extraction process
Automate Express to Streamline Differential Extraction process
 
Final Report 402
Final Report 402Final Report 402
Final Report 402
 
Total Legal: A “Joint” Journey into the Chemistry of Cannabinoids
Total Legal: A “Joint” Journey into the Chemistry of CannabinoidsTotal Legal: A “Joint” Journey into the Chemistry of Cannabinoids
Total Legal: A “Joint” Journey into the Chemistry of Cannabinoids
 
HPLC: A Nifty tool for Herbal Analysis
HPLC: A Nifty tool for Herbal AnalysisHPLC: A Nifty tool for Herbal Analysis
HPLC: A Nifty tool for Herbal Analysis
 
Getting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in RadiopharmaceuticalsGetting Ahead of the Evolving Landscape in Radiopharmaceuticals
Getting Ahead of the Evolving Landscape in Radiopharmaceuticals
 
123 yo yo.pdf
123 yo yo.pdf123 yo yo.pdf
123 yo yo.pdf
 
Trial examining the impact of various biological organic and fertiliser treat...
Trial examining the impact of various biological organic and fertiliser treat...Trial examining the impact of various biological organic and fertiliser treat...
Trial examining the impact of various biological organic and fertiliser treat...
 
Lignocellulose Biomass- Hydrolysis & Fermentation Lab Protocols
Lignocellulose Biomass- Hydrolysis & Fermentation Lab ProtocolsLignocellulose Biomass- Hydrolysis & Fermentation Lab Protocols
Lignocellulose Biomass- Hydrolysis & Fermentation Lab Protocols
 
4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...4th International Conference on Process Analytical Technologies in Organic Pr...
4th International Conference on Process Analytical Technologies in Organic Pr...
 
Research on Safety of Electronic Cigarettes - Dr. Konstantinos Farsalinos
Research on Safety of Electronic Cigarettes - Dr. Konstantinos FarsalinosResearch on Safety of Electronic Cigarettes - Dr. Konstantinos Farsalinos
Research on Safety of Electronic Cigarettes - Dr. Konstantinos Farsalinos
 
Dr konstantinos farsalinos the royal society 11 13
Dr konstantinos farsalinos the royal society 11 13Dr konstantinos farsalinos the royal society 11 13
Dr konstantinos farsalinos the royal society 11 13
 
Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...
Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...
Rapid In Vivo Assessment of Bioactivity in Zebrafish: High Content Data for P...
 
Chemical Analysis Facility
Chemical Analysis FacilityChemical Analysis Facility
Chemical Analysis Facility
 
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
Polysaccharide based nanoparticles for encapsualtion and release of antineopl...
 
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC METHOD FOR D...
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC  METHOD FOR D...DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC  METHOD FOR D...
DEVELOPMENT AND VALIDATION OF SPECTROSCOPIC AND CHROMATOGRAPHIC METHOD FOR D...
 
Tongkat Ali Extraction Process
Tongkat Ali Extraction ProcessTongkat Ali Extraction Process
Tongkat Ali Extraction Process
 
Are You Ready for Harmful Algal Bloom Season? | Preparing for HAB Monitoring
Are You Ready for Harmful Algal Bloom Season? | Preparing for HAB MonitoringAre You Ready for Harmful Algal Bloom Season? | Preparing for HAB Monitoring
Are You Ready for Harmful Algal Bloom Season? | Preparing for HAB Monitoring
 
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...
FDA Feedback Regarding Chemistry for Toxicological Risk Assessment – How to M...
 
Radionuclide imaging
Radionuclide imagingRadionuclide imaging
Radionuclide imaging
 
academic / small company collaborations for rare and neglected diseasesv2
 academic / small company collaborations for rare and neglected diseasesv2 academic / small company collaborations for rare and neglected diseasesv2
academic / small company collaborations for rare and neglected diseasesv2
 

TAM-D.5

  • 1. Characterization of Long-Lived Cyclotron Produced Activation Metal Impurities Retained in FASTlab FDG Cassettes during Synthesis of Radiolabeled 2-[18F] fluoro-2- deoxy-D-glucose (FDG) Presented at the 60th Annual Health Physics Society Meeting Paul Swearingen, MHP MOLECULAR IMAGING PROGRAM AT STANFORD STANFORD HEALTH PHYSICS
  • 2. Introduction  PET radiopharmaceutical production on the rise › Proportional increase in PET production sites worldwide › Produced via Cyclotron  Stanford Cyclotron and Radiochemistry Facility (CRF) › F18 radiolabeled FDG production › Supports clinical and research use › Daily production  Health Physics Functions › Radioactive materials license › Personnel monitoring › ALARA › Radioactive waste Paul Swearingen, MHP
  • 3. 3 Cyclotron and Radiochemistry Facility (CRF)  16.5 MeV General Electric PETtrace Cyclotron accelerator › Protons/deuterons fired onto target › Up to 6 targets › Designed to produce common PET radioisotopes  Radiochemistry Systems › Automated/Isolated › Stand-alone process units for specific radioisotopes › Housed in lead shielded process cabinet Paul Swearingen, MHP
  • 4. 4 FASTlab Synthesizer  Automated radiochemistry system › GE Heath Care Design › converts externally produced 18F-fluoride/into [18F]-Tracer  FDG production via individual tracer cassettes  Stanford uses FDG citrate cassettes Paul Swearingen, MHP
  • 5. FDG Citrate Cassette End Tubing Eluent Vial Alumina Cartridge Purification Cartridge Right Hand 6 ml Syringe Trapping Cartridge Reaction Vessel Reagent Vials Hydrolysis Cartridge Transfer Tubing Left Hand 6 ml Syringe Paul Swearingen, MHP
  • 6. Target Irradiation  Charged particles accelerated and deflected onto target › Enriched O-18 water target › Secondary reactions in surrounding materials › Proton/neutron activation in target and housing/shielding  Activation metals leach into target water from surrounding materials › Mainly from Havar Foils • Co, Cr, Fe, Ni, Mn, W, Mo metals › Cassettes retain activation metals • Activity not uniformly distributed among components Paul Swearingen, MHP
  • 7. 7 Radioactive Waste  Short-lived wastes › F18 and other PET isotopes › Decay-in-storage method (DIS)  Long-lived wastes › Target components › FDG Cassettes › Accumulation of waste › Current disposal method vs. DIS method › Need to characterize • Isotopes, activities, cassette components Paul Swearingen, MHP
  • 8. Waste Characterization  Unknown isotopes and activity amounts › Gamma spectroscopy using HPGe  Characterize isotopes in cassettes › Determine half-lives and activities › Determine required DIS time  Determine radioactive components › Distribution of isotope activities › Reduce overall volume of waste Paul Swearingen, MHP
  • 9. Experiment Steps  Collect cassettes from Cyclotron › Coordinate with radiochemistry staff › Separate components into 11 countable samples › Collected total of 5 cassettes over 5 month period › Random selection of cassettes  Count samples using HPGe › 12 hour counting time › Repeatable geometry › Background counts › Acquire gamma ray spectra of each sample › Collect activity and isotope data  Data Analysis › Determine distribution of isotopes/activities in each sample › Determine required DIS times Paul Swearingen, MHP
  • 11. Stanford HPGe Lab  Ortec GMX Series Coaxial Detector System › Model GMX20-70-CW › N-Type Crystal › Bias Voltage at 4000V › DSPEC-jr. 2.0 MCA › GammaVision v7.02 Software  Energy and Efficiency Calibration › Eckert & Ziegler Multi-gamma check source (AD-7066) › 60 – 1836 KeV  Lead shielded enclosure › Low sample counts › Important to minimize background › 12 hr background spectrum before every run Paul Swearingen, MHP
  • 12. Isotope Composition at Irradiation Co-56, 33.4% Co-57, 0.9% Co-58, 9.4% Cr-51, 22.3% Mn-52, 7.7% Mn-54, 0.5% Ni-57, 5.3% Re-181, 1.7% Re-182, 0.4% Re-184, 0.4% Tc-95, 5.7% Tc-95m, 1.8% Tc-96, 9.0% V-48, 0.1% Y-88, 1.2% Zn-65, 0.3% Zr-89, 0.1% Paul Swearingen, MHP
  • 13. Activity by Counting Sample Right Hand 6 ml Syringe, 0.5% Purification Cartridge, 0.9% Alumina Cartridge, 6.7% Transfer Tubing, 1.6% Hydrolysis Cartridge, 5.0% Reagent Vials Unit, 0.1% Reaction Vessle, 8.9% Left Hand 6 ml Syringe, 13.0% Trapping Cartridge, 47.6% Eluent Vial + 1 ml Syringe, 11.9% End Tubing, 3.6% Paul Swearingen, MHP
  • 14. 14 10 CFR PART 30 —RULES OF GENERAL APPLICABILITY TO DOMESTIC LICENSING OF BYPRODUCT MATERIAL Exemption Limits  § 30.70 Schedule A--Exempt concentrations › Specific activity limits for various isotopes › For multiple isotopes, combined ratio must not exceed unity Isotope Concentration [μCi/mg] Cd-109 2.00E-03 Co-56 1.00E-06 Co-57 5.00E-03 Co-58 1.00E-03 Cr-51 2.00E-02 Mn-52 3.00E-04 Mn-54 1.00E+00 Ni-57 1.00E-03 Re-182 1.00E-06 Re-183 6.00E-03 Re-184 1.00E-06 Re-186 9.00E-04 Tc-95m 1.00E-06 Tc-96 1.00E-03 V-48 3.00E-04 W-181 1.00E-06 Y-88 1.00E-06 Zn-65 1.00E-03 Paul Swearingen, MHP
  • 15. Summary of Results  16 isotopes in 5 cassettes › 0.8 – 312 day half-lives › 122 – 1434 KeV gammas › 0.01 – 1.2 uCi activities  Stanford “Decay-in-Storage” (DIS) policy › Per our license with State of California › DIS for 7 half-lives, if half-life less than 120 d  All but 2 components are non-exempt › Co-56/Tc-95m › 77.2 and 62 day half-lives Paul Swearingen, MHP
  • 16. Conclusions  Co-56 is the longest lived, non-exempt isotope › 77.2 day half life › 540 day DIS time per cassette › After DIS  dispose as non-radioactive waste  DIS of entire cassette better option  All but 2 components considered non-radioactive › ≈22% volume reduction  Insufficient statistics to verify radioactive vs. non-radioactive components › Small sample size (n = 5)  Time, Distance, Shielding › Dose considerations working directly with cassettes Paul Swearingen, MHP
  • 17. Future Considerations  Develop Standard Operating Procedure for DIS and handling of Cassettes  Institute routine waste pick-up policy for wastes containing activated metals › Daily throughput  estimate of 30 cassettes/month  Further analysis › More Cassettes, better statistics  determine radioactive vs. non- radioactive components with greater degree of certainty › Relationship between cyclotron irradiation conditions and isotope composition › Cost-benefit analysis  ALARA considerations › Dose to worker estimates › Shielding Paul Swearingen, MHP
  • 18. Acknowledgements Dawn Banghart, CHP Stanford Health Physics Lance Phillips, CHP Stanford Health Physics Don Samaan, NRRPT Stanford Health Physics Marshall Wen Stanford Health Physics Fred T. Chin, PhD Assistant Professor (Research), Assistant Professor (Research), Radiology- Molecular Imaging Program at Stanford Bin Shen, PhD Radiochemistry Senior Research Associate George Montoya Cyclotron Production Technician Paul Swearingen, MHP
  • 20. References Ferguson, D. et al., “Measurement of long lived radioactive impurities retained in the disposable cassettes on the Tracerlab MX system during the production of F18[FDG]”, Appl. Radiat. Isotopes (2011) O’Donnell, R.G., “Measurement of the residual radioactivity induced in the front foil of a target assembly in a modern medical cyclotron”, Appl. Radiat. Isotopes (2003) LNHB Recommended Data. LNHB, 21 May 2015. Web. 15 June 2015. <http://www.nucleide.org/DDEP_WG/DDEPdata.htm>. Radionuclide Transofrmations: Energy and Intensity of Emissions. ICRP Publication 38 ed. Vol. 11-13. Oxford: Pergamon, 1983. Print. PETtrace Reference Manual. Milwuakee: GE Medical Systems, 1998. Print. FASTlab FDG Citrate Application Manual. Waukesha: GE Healthcare. Print. Paul Swearingen, MHP